MEDICAL RECOMMENDATIONS

Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations

National Advisory Committee on ImmunizationImmunization2023Official publication

ASEM documentary overview

Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations”. Summary of NACI guidance on safety and recommended use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations in Canada.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document

Related guidelines

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada